LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2020ACC: 0001209191-20-030765
Officer· Chief Financial Officer
Since Jun 2018
+98.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
98.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+49.00
Price / share
$24.00
Trade value
$1.18K
% of position
1.9%
5/15/2020
2.62K→2.67K
Total
Net shares
+49.00
Net value
$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2020 | A · Award | +49.00 | $24.00 | $1.18K | 1.9% | 2.62K | 2.67K |
| Total | +49.00 | $1.18K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
49.00 shares
Shares
+49.00
Strike price
28.24
Held after
49.00
Exercisable
—
5/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock49.00 shares | 5/15/2020 | A · Award | +49.00 | 28.24 | — | 49.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported